ReviewFASEB journal : official publication of the Federation of American Societies for Experimental Biology2026
Human α2-Macroglobulin: Architecture, Mechanisms, and Functional Implications.
Review in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Correction to "Human α2-Macroglobulin: Architecture, Mechanisms, and Functional Implications".FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026Article
Corrections and comments
- Erratum issued
Authors and funding
3 authors.
Funding
Abstract
α2-Macroglobulin (α2M) is a large glycoprotein and one of the most abundant proteins found in the plasma of vertebrates and in the hemolymph of invertebrates. It performs several important functions in the innate immune system, serving as a pan-protease inhibitor and contributing to essential processes, such as cytokine and hormone transport. It also triggers diverse cellular responses, critical for the functioning of both eukaryotic and some prokaryotic biological systems. Here, we focus on the human α2-macroglobulin (hα2M) molecule, compiling relevant information from recent studies on its structure and how this relates to its unique protease capture mechanism. In addition, we summarize other findings accumulated over 50 years of literature on hα2M. We also discuss its distinctive electrophoretic behavior, its dimeric form, and its potential role in inflammatory environments, as well as the basic unit of hα2M for protease capture. We summarize some challenges encountered in hα2M structural studies, a distinctive mechanism of incorporation of non-proteolytic ligands, and remarks and details on its purification and storage. Although the clinical use of hα2M is currently limited mainly to its role as a secondary biomarker for certain disorders, new therapeutic approaches have begun to emerge in initial studies over the past decade. The study of hα2M remains highly relevant for understanding unknown aspects of the innate immune system, developing new therapies, elucidating infection and inflammation processes, exploring potential links to mechanisms of cancer resistance, and advancing other fields critically important to translational and clinical research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.